Cargando…
Impact of a blood-stage vaccine on Plasmodium vivax malaria
BACKGROUND: There are no licensed vaccines against Plasmodium vivax, the most common cause of malaria outside of Africa. METHODS: We conducted two Phase I/IIa clinical trials to assess the safety, immunogenicity and efficacy of two vaccines targeting region II of P. vivax Duffy-binding protein (PvDB...
Autores principales: | Hou, Mimi M., Barrett, Jordan R., Themistocleous, Yrene, Rawlinson, Thomas A., Diouf, Ababacar, Martinez, Francisco J., Nielsen, Carolyn M., Lias, Amelia M., King, Lloyd D. W., Edwards, Nick J., Greenwood, Nicola M., Kingham, Lucy, Poulton, Ian D., Khozoee, Baktash, Goh, Cyndi, Mac Lochlainn, Dylan J., Salkeld, Jo, Guilotte-Blisnick, Micheline, Huon, Christèle, Mohring, Franziska, Reimer, Jenny M., Chauhan, Virander S., Mukherjee, Paushali, Biswas, Sumi, Taylor, Iona J., Lawrie, Alison M., Cho, Jee-Sun, Nugent, Fay L., Long, Carole A., Moon, Robert W., Miura, Kazutoyo, Silk, Sarah E., Chitnis, Chetan E., Minassian, Angela M., Draper, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164524/ https://www.ncbi.nlm.nih.gov/pubmed/35664997 http://dx.doi.org/10.1101/2022.05.27.22275375 |
Ejemplares similares
-
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
por: Hou, Mimi M., et al.
Publicado: (2023) -
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans
por: Martinez, Francisco J., et al.
Publicado: (2023) -
Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax
por: Gupta, Sonal, et al.
Publicado: (2018) -
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
por: Salkeld, Jo, et al.
Publicado: (2022) -
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
por: Miura, Kazutoyo, et al.
Publicado: (2023)